New Zealand Markets closed

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4500+0.0100 (+0.69%)
At close: 04:00PM EDT
1.4300 -0.02 (-1.38%)
After hours: 07:59PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts3233
Avg. Estimate0.04-0.3-2.12-1.16
Low estimate-0.4-0.34-2.54-2
High estimate0.87-0.26-1.33-0.39
Year ago EPS-0.9-1.01-2.91-2.12
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts3133
Avg. Estimate23.2M1.9M28.96M20.8M
Low estimate1.6M1.9M7.1M4.8M
High estimate66M1.9M72.1M50M
Year ago sales2.74M2.07M18.26M28.96M
Sales growth (year/est)745.50%-8.20%58.60%-28.20%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.75-0.87-0.93-0.3
Actual EPS-0.9-1.01-0.87-0.33
Difference-0.15-0.140.06-0.03
Surprise %-20.00%-16.10%6.50%-10.00%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate0.04-0.3-2.12-1.16
7 days ago0.04-0.3-2.12-1.16
30 days ago0.26-0.34-1.93-1.19
60 days ago0.26-0.34-1.93-1.19
90 days ago-0.36-0.37-2.43-1.51
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSPROIndustrySector(s)S&P 500
Current qtr.104.40%N/AN/AN/A
Next qtr.70.30%N/AN/AN/A
Current year27.10%N/AN/AN/A
Next year45.30%N/AN/AN/A
Next 5 years (per annum)36.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A